Patricia J. Sime

Patricia J. Sime

Auto-generated profile, based on publicly available information

Patricia J. Sime

Virginia Commonwealth University

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in Seminars in Immunology
Verified
Journal Article
Closed access
WJWalker A. Julliard
Walker A. Julliard
YMYu Par Aung Myo
Yu Par Aung Myo
APApostolos Perelas
Apostolos Perelas
PJPeter D. Jackson
Peter D. Jackson
TTThomas H. Thatcher
Thomas H. Thatcher
PSPatricia J. Sime
Patricia J. Sime

5 October 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
MFMargaret A.T. Freeberg
Margaret A.T. Freeberg
APApostolos Perelas
Apostolos Perelas
JRJane K. Rebman
Jane K. Rebman
RPRichard P. Phipps
Richard P. Phipps
TTThomas H. Thatcher
Thomas H. Thatcher
PSPatricia J. Sime
Patricia J. Sime

17 September 2020 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
ARAshley R. Rackow
Ashley R. Rackow
DNDavid Nagel
David Nagel
CMClaire McCarthy
Claire McCarthy
JJJennifer Judge
Jennifer Judge
SLShannon Lacy
Shannon Lacy
PSPatricia J. Sime
Patricia J. Sime
Pulmonary fibrosis is a devastating, progressive disease and carries a prognosis worse than most cancers. Despite ongoing research, the mechanisms that underlie disease pathogenesis remain only partially understood. However, the self-perpetuating nature of pulmonary fibrosis has led several researchers to propose the existence of pathological signalling loops. According to this hypothesis, the normal wound-healing process becomes corrupted and results in the progressive accumulation of scar tissue in the lung. In addition, several negative regulators of pulmonary fibrosis are downregulated and, therefore, are no longer capable of inhibiting these feed-forward loops. The combination of pathological signalling loops and loss of a checks and balances system ultimately culminates in a process of unregulated scar formation. This review details specific signalling pathways demonstrated to play a role in the pathogenesis of pulmonary fibrosis. The evidence of detrimental signalling loops is elucidated with regard to epithelial cell injury, cellular senescence and the activation of developmental and ageing pathways. We demonstrate where these loops intersect each other, as well as common mediators that may drive these responses and how the loss of pro-resolving mediators may contribute to the propagation of disease. By focusing on the overlapping signalling mediators among the many pro-fibrotic pathways, it is our hope that the pulmonary fibrosis community will be better equipped to design future trials that incorporate the redundant nature of these pathways as we move towards finding a cure for this unrelenting disease.

21 May 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PDParker F Duffney
Parker F Duffney
AEA Karim Embong
A Karim Embong
CMConnor C McGuire
Connor C McGuire
TTThomas H Thatcher
Thomas H Thatcher
RPRichard P Phipps
Richard P Phipps
PSPatricia J Sime
Patricia J Sime
Cigarette smoke exposure is a risk factor for many pulmonary diseases, including Chronic Obstructive Pulmonary Disease (COPD). Cigarette smokers are more prone to respiratory infections with more severe symptoms. In those with COPD, viral infections can lead to acute exacerbations resulting in lung function decline and death. Epithelial cells in the lung are the first line of defense against inhaled insults such as tobacco smoke and are the target for many respiratory pathogens. Endocytosis is an essential cell function involved in nutrient uptake, cell signaling, and sensing of the extracellular environment, yet, the effect of cigarette smoke on epithelial cell endocytosis is not known. Here, we report for the first time that cigarette smoke alters the function of several important endocytic pathways in primary human small airway epithelial cells. Cigarette smoke exposure impairs clathrin-mediated endocytosis and fluid phase macropinocytosis while increasing caveolin mediated endocytosis. We also show that influenza virus uptake is enhanced by cigarette smoke exposure. These results support the concept that cigarette smoke-induced dysregulation of endocytosis contributes to lung infection in smokers. Targeting endocytosis pathways to restore normal epithelial cell function may be a new therapeutic approach to reduce respiratory infections in current and former smokers.

22 January 2025 in The American Journal of Pathology
Verified
Journal Article
Closed access
MFMargaret A.T. Freeberg
Margaret A.T. Freeberg
SCSarah V. Camus
Sarah V. Camus
VRValentina Robila
Valentina Robila
APApostolos Perelas
Apostolos Perelas
TTThomas H. Thatcher
Thomas H. Thatcher
PSPatricia J. Sime
Patricia J. Sime

1 March 2022 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
ARAshley R. Rackow
Ashley R. Rackow
JJJennifer L. Judge
Jennifer L. Judge
CWCollynn F. Woeller
Collynn F. Woeller
PSPatricia J. Sime
Patricia J. Sime
RKR. Matthew Kottmann
R. Matthew Kottmann
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease. The pathogenesis of IPF is not completely understood. However, numerous genes are associated with the development and progression of pulmonary fibrosis, indicating there is a significant genetic component to the pathogenesis of IPF. Epigenetic influences on the development of human disease, including pulmonary fibrosis, remain to be fully elucidated. In this paper, we identify miR-338-3p as a microRNA severely downregulated in the lungs of patients with pulmonary fibrosis and in experimental models of pulmonary fibrosis. Treatment of primary human lung fibroblasts with miR-338-3p inhibits myofibroblast differentiation and matrix protein production. Published and proposed targets of miR-338-3p such as TGFβ receptor 1, MEK/ERK 1/2, Cdk4, and Cyclin D are also not responsible for the regulation of pulmonary fibroblast behavior by miR-338-3p. miR-338-3p inhibits myofibroblast differentiation by preventing TGFβ-mediated downregulation of phosphatase and tensin homolog (PTEN), a known antifibrotic mediator.